Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Compass Therapeutics LLC”

80 pharma patents match "Compass Therapeutics LLC" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 80
Index total 30,257
Page 2 / 4

Quick answer

This filtered view shows 80 pharmaceutical patents matching "Compass Therapeutics LLC" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

80 results for “Compass Therapeutics LLC” · 30,257 patents in full index Clear search

  1. US 11033626

    Progesterone formulations having a desirable pk profile

    Compass Therapeutics LLC · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  2. US 10973869

    Methods of treating cardiomyopathy associated with genetic disorders

    Compass Therapeutics LLC · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted
  3. US 10960045

    Methods and compositions for the treatment of epidermolysis bullosa

    Compass Therapeutics LLC · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted
  4. US 10912783

    Formulations for solubilizing hormones

    Compass Therapeutics LLC · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted
  5. US 10888516

    Soluble estradiol capsule for vaginal insertion

    Compass Therapeutics LLC · Granted Jan 12, 2021 · Expires Jan 7, 2041

    granted
  6. US 10835487

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Compass Therapeutics LLC · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted
  7. US 10806697

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Compass Therapeutics LLC · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted
  8. US 10806740

    Natural combination hormone replacement formulations and therapies

    Compass Therapeutics LLC · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted
  9. US 10716851

    Agonist antibodies that bind human CD137 and uses thereof

    Compass Therapeutics LLC · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted
  10. US 10675288

    Natural combination hormone replacement formulations and therapies

    Compass Therapeutics LLC · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted
  11. US 10668082

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Compass Therapeutics LLC · Granted Jun 2, 2020 · Expires May 28, 2040

    granted
  12. US 10639375

    Progesterone formulations

    Compass Therapeutics LLC · Granted May 5, 2020 · Expires Apr 30, 2040

    granted
  13. US 10568891

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Compass Therapeutics LLC · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted
  14. US 10537581

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Compass Therapeutics LLC · Granted Jan 21, 2020 · Expires Jan 16, 2040

    granted
  15. US 10532059

    Steroid hormone pharmaceutical composition

    Compass Therapeutics LLC · Granted Jan 14, 2020 · Expires Jan 9, 2040

    granted
  16. US 10471148

    Progesterone formulations having a desirable PK profile

    Compass Therapeutics LLC · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted
  17. US 10471072

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Compass Therapeutics LLC · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted
  18. US 10434175

    Agonist antibodies that bind human CD137 and uses thereof

    Compass Therapeutics LLC · Granted Oct 8, 2019 · Expires Oct 3, 2039

    granted
  19. US 10398708

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Compass Therapeutics LLC · Granted Sep 3, 2019 · Expires Aug 29, 2039

    granted
  20. US 10369098

    Methods for localized drug delivery

    Compass Therapeutics LLC · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  21. US 10350292

    Agonist antibodies that bind human CD137 and uses thereof

    Compass Therapeutics LLC · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted
  22. US 10328087

    Formulations for solubilizing hormones

    Compass Therapeutics LLC · Granted Jun 25, 2019 · Expires Jun 20, 2039

    granted
  23. US 10286077

    Steroid hormone compositions in medium chain oils

    Compass Therapeutics LLC · Granted May 14, 2019 · Expires May 9, 2039

    granted
  24. US 10279038

    Agonist antibodies that bind human CD137 and uses thereof

    Compass Therapeutics LLC · Granted May 7, 2019 · Expires May 2, 2039

    granted